Filtered By:
Source: Medscape Today Headlines
Condition: Bleeding

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 17 results found since Jan 2013.

DAPT vs. Aspirin in Patients With Stroke or TIA DAPT vs. Aspirin in Patients With Stroke or TIA
This study found that compared with aspirin alone, DAPT given within 24 hours of high-risk TIA or mild to moderate stroke reduces the risk of recurrent stroke, but comes with higher risk of bleeding.Stroke
Source: Medscape Today Headlines - July 5, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Higher Incidence of Ischemic Stroke in Patients Taking NOACs Higher Incidence of Ischemic Stroke in Patients Taking NOACs
Does the reduced risk of nontraumatic bleeding in patients taking NOACs as opposed to warfarin come at the cost of a higher risk of ischemic stroke?Stroke
Source: Medscape Today Headlines - December 17, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Short Course of Aspirin, Clopidogrel Cuts Stroke RiskShort Course of Aspirin, Clopidogrel Cuts Stroke Risk
Brief combination therapy reduces recurrent stroke over aspirin alone, without increasing bleeding risk, CHANCE trial results show. Medscape Medical News
Source: Medscape Today Headlines - February 11, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Heparins Not Recommended in Acute Stroke Heparins Not Recommended in Acute Stroke
Analyzing individual-patient data from the 5 largest trials of heparin in acute stroke has not been able to define a group of patients in whom the benefit outweighs the bleeding risk. Medscape Medical News
Source: Medscape Today Headlines - May 10, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

SSRIs After Stroke: Yes or No?SSRIs After Stroke: Yes or No?
A large follow-up study reveals the potential effects of SSRI after acute stroke on bleeding risk, cardiovascular risk, and mortality. Medscape Psychiatry
Source: Medscape Today Headlines - September 5, 2013 Category: Consumer Health News Tags: Psychiatry Commentary Source Type: news

Novel Anticoagulants for Stroke Prevention in AF and CKDNovel Anticoagulants for Stroke Prevention in AF and CKD
Studies show increased risk of stroke, bleeding and death in patients with chronic kidney disease and AF, so why is anticoagulation still underutilized? Expert Review of Cardiovascular Therapy
Source: Medscape Today Headlines - November 13, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Dabigatran Concentrations and Ischemic Stroke in AFDabigatran Concentrations and Ischemic Stroke in AF
Learn more on how ischemic stroke and bleeding outcomes are tied to dabigatran plasma concentrations. Journal of the American College of Cardiology
Source: Medscape Today Headlines - March 6, 2014 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Oral Anticoagulation in ESRD and AF: Just Say No to Drugs? Oral Anticoagulation in ESRD and AF: Just Say No to Drugs?
The presence of CKD in patients with AF is associated with increased stroke risk--but also a heightened risk of bleeding. Are anticoagulants safe for stroke prevention in these patients?Heart
Source: Medscape Today Headlines - June 27, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Equivalent Outcomes With Corevalve and Sapien TAVIEquivalent Outcomes With Corevalve and Sapien TAVI
At 30 days, there was no difference in the rate of all-cause mortality, cardiovascular mortality, MI, stroke, or device success, as well as no major difference in the rate of major vascular complications or life-threatening bleeding events. There was, however, an increased need for permanent pacemaker implantation with the CoreValve compared with the Edwards Sapien transcatheter aortic valve. Heartwire
Source: Medscape Today Headlines - January 18, 2013 Category: Consumer Health News Tags: Cardiology News Source Type: news

Dabigatran 'Real Life' Results Suggest Caution NeededDabigatran 'Real Life' Results Suggest Caution Needed
New data from real-life experience of dabigatran for stroke prevention in AF show that it is often used outside prescribing recommendations, and the risk for both thromboembolism and bleeding may be raised in patients switched from warfarin. Medscape Medical News
Source: Medscape Today Headlines - May 15, 2013 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Apixaban vs Warfarin in Patients With Atrial FibrillationApixaban vs Warfarin in Patients With Atrial Fibrillation
Are the rates of stroke/systemic embolism and major bleeding lower among patients assigned to apixaban -- irrespective of prior vitamin K antagonist use? American Heart Journal
Source: Medscape Today Headlines - November 7, 2013 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Apixaban vs. Warfarin and Aspirin in Atrial FibrillationApixaban vs. Warfarin and Aspirin in Atrial Fibrillation
Compare the impact of two regimens on stroke and major bleeding -- in patients with atrial fibrillation. European Heart Journal
Source: Medscape Today Headlines - March 11, 2014 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Transition From Blinded Study Drug to Open-LabelTransition From Blinded Study Drug to Open-Label
Learn about an end-of-trial transition plan to minimize bleeding and stroke risks during a critical period. Journal of the American College of Cardiology
Source: Medscape Today Headlines - September 8, 2014 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Which AFib Patients Should Receive Anticoagulation? Which AFib Patients Should Receive Anticoagulation?
Two clinicians discuss the newest approaches to risk scoring for bleeding and stroke in order to identify the patients who should receive anticoagulation.American College of Cardiology & Medscape
Source: Medscape Today Headlines - March 29, 2018 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news

Comparisons Between OACs Among Older Nonvalvular AF Patients Comparisons Between OACs Among Older Nonvalvular AF Patients
This study compared the risk of stroke and major bleeding with NOACs vs. warfarin among patients 80 years of age and older with nonvalvular atrial fibrillation.Journal of the American Geriatrics Society
Source: Medscape Today Headlines - September 13, 2019 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news